Bloodied Biotech Stocks Unlikely to Find Earnings-Season Healing

(Bloomberg) -- Investors in beaten-up biotech stocks looking for something to stem the bleeding probably won’t find it in first-quarter earnings.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.